Q4 2011 · —
Revenue$203.52M$203.52M +4.8% vs Q4 2010+0.7% vs Q3 2011
Net Income$4.56M$4.56M −75.8% vs Q4 2010−59.4% vs Q3 2011
EPS Diluted$0.16$0.16 −74.6% vs Q4 2010−59.0% vs Q3 2011
Gross Profit$120,783,000−1.7%
Operating Incomederived$7,749,000−67.9%
Operating Cash Flowderived$34,695,000+22.0%
Free Cash Flowderived$21,651,000+112.5%
Margins · derived
Gross margin59.3%−3.9 pt vs Q4 2010
Operating margin3.8%−8.6 pt vs Q4 2010
Net margin2.2%−7.4 pt vs Q4 2010
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q4 2011 | Q4 2010 | Q4 2009dderived from reported figures |
|---|---|---|---|
| Revenue | $203.52M | $194.13M | — |
| Net Income | $4.56M | $18.81M | — |
| EPS Diluted | $0.16 | $0.63 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR